Ginkgo bioworks reports second quarter 2024 financial results

Ginkgo provides update on its restructuring process including estimated annualized cost savings of over $85 million from reduction in force  boston , aug. 8, 2024 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna, "ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the second quarter ended june 30, 2024. the update, including a webcast slide presentation with additional details on the second quarter and supplemental financial information, will be available at investors.ginkgobioworks.com.
DNA Ratings Summary
DNA Quant Ranking